Pharmaceuticals

Global Hypercholesterolemia Drugs Market 2016-2020

  • TEC629318
  • 98 Pages
  • July 2016
  • Pharmaceuticals
About Hypercholesterolemia

Hypercholesterolemia is characterized by high levels of total cholesterol and LDL-C in the blood. High cholesterol levels can cause CVDs such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL.Blood cholesterol contains individual components such as LDL-C and HDL-C. LDL carries cholesterol to the body and HDL removes cholesterol from the cells by reversing cholesterol transport to the liver.

Technavios analysts forecast the global hypercholesterolemia drugs market to decline at a CAGR of 6.78% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global hypercholesterolemia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generics, and off-label drugs used to treat hypercholesterolemia.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Hypercholesterolemia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Aegerion Pharmaceuticals
AstraZeneca
Merck
Pfizer
Sanofi

Other prominent vendors
Alnylam Pharmaceuticals
Amarin
Amgen
AtheroNova
Aurobindo Pharma
Biocon
Biospherics
Bristol-Myers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
CymaBay Therapeutics
Daewoong Pharmaceutical
Daiichi Sankyo
Eli Lilly
Esperion Therapeutics
GlaxoSmithKline
HanAll BioPharma
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kowa Company
Laboratoires
Livzon Pharmaceutical
Lupin Pharmaceuticals
Madrigal Pharmaceuticals
Merz Pharmaceuticals
Mylan
Novartis
Regeneron Pharmaceuticals
ReGenX Biosciences
Santaris Pharma
Serometrix
Sun Pharmaceutical
Arbutus Biopharma
Teva Pharmaceuticals
Torrent Pharmaceuticals
Zydus Cadila

Market driver
Rising prevalence of chronic diseases
For a full, detailed list, view our report

Market challenge
Loss of patent exclusivity of branded therapies
For a full, detailed list, view our report

Market trend
Expected entry of cost-effective OTC versions
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.






Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

January 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

January 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

January 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

January 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

January 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

January 2018| $2850 | Pre Book Price:$2494

2018 © Copyright Big Market Research

View Pricing >>